Buszewska-Forajta, M.; Pomastowski, P.; Monedeiro, F.; Walczak-Skierska, J.; Markuszewski, M.; Matuszewski, M.; Markuszewski, M.J.; Buszewski, B.
Lipidomics as a Diagnostic Tool for Prostate Cancer. Cancers 2021, 13, 2000.
https://doi.org/10.3390/cancers13092000
AMA Style
Buszewska-Forajta M, Pomastowski P, Monedeiro F, Walczak-Skierska J, Markuszewski M, Matuszewski M, Markuszewski MJ, Buszewski B.
Lipidomics as a Diagnostic Tool for Prostate Cancer. Cancers. 2021; 13(9):2000.
https://doi.org/10.3390/cancers13092000
Chicago/Turabian Style
Buszewska-Forajta, Magdalena, Paweł Pomastowski, Fernanda Monedeiro, Justyna Walczak-Skierska, Marcin Markuszewski, Marcin Matuszewski, Michał J. Markuszewski, and Bogusław Buszewski.
2021. "Lipidomics as a Diagnostic Tool for Prostate Cancer" Cancers 13, no. 9: 2000.
https://doi.org/10.3390/cancers13092000
APA Style
Buszewska-Forajta, M., Pomastowski, P., Monedeiro, F., Walczak-Skierska, J., Markuszewski, M., Matuszewski, M., Markuszewski, M. J., & Buszewski, B.
(2021). Lipidomics as a Diagnostic Tool for Prostate Cancer. Cancers, 13(9), 2000.
https://doi.org/10.3390/cancers13092000